Patent · US Active

3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

US10647701B2 · kind B2 · utility

6Cited by

5References

16Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Rohan Eric John Beckwith · Cambridge, US
Simone BONAZZI · Cambridge, US
Artiom CERNIJENKO · Cambridge, US
Ritesh Bhanudasji Tichkule · Cambridge, US
Michael Scott Visser · Braintree, US

Key dates

Filing date	Aug 5, 2019
Grant date	May 12, 2020
Priority date	—
Expiry date	Aug 5, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present disclosure provides a compound of Formula (I′):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.